Sansero Life Sciences

We're committed to helping overcome the global mental health crisis by creating innovative, effective and accessible psilocybin-based medicines

[Sansero Life Sciences @Sansero_Life]

Washington DC became the latest jurisdiction to decriminalize the use of psychedelic drugs. Advocates say substances like psilocybin can treat mental health issues like depression, anxiety, eating disorders, pain, and PTSD.
https://t.co/8ZdnjIVhHm

[Sansero Life Sciences @Sansero_Life]

Dr. Darryl Hudson, Chief Science Officer at @Sansero_Life, will be speaking about his expertise in molecular biology, neuroscience, and genetics in psychedelics. Join him on Feb. 21 from 12-12:30 pm to watch his session "Healing Through Plant Medicines": https://t.co/S05zdas7Lf

[Sansero Life Sciences @Sansero_Life]

The #FDA granted researchers a “breakthrough therapy designation” so they can study mushrooms.

Read to learn how #psilocybin could be legal for #therapy by this year: https://t.co/IfarxLP3uy

[Sansero Life Sciences @Sansero_Life]

John Hopkins Medicine researchers studied the impact of #psilocybin on the claustrum, moving them closer to understanding mechanisms underlying how psilocybin works in the brain. Find out what happens in the claustrum when people are on #psychedelics: https://t.co/WICsR0QMBO

[Sansero Life Sciences @Sansero_Life]

“#Psilocybin currently is being evaluated as a treatment for various psychiatric conditions and there is increasing interest in developing related psychedelic drugs."

Read to learn what motivates people to use #psychedelics: https://t.co/PsM6C1ARTZ

[Sansero Life Sciences @Sansero_Life]

"Psychedelic treatment... appears to be a less painful portal to accessing the interface of the unconscious and the body."

Read to find out how #psilocybin can be used as a treatment for healing past trauma: https://t.co/lJVs80c8pG

#MentalHealth #Psychedelics #Trauma

[Sansero Life Sciences @Sansero_Life]

Oregon made history on Nov. 3 by being the first state to legalize #psilocybin and the first jurisdiction in the world to lay out plans for regulating the drug's therapeutic use. Read to learn more: https://t.co/9T5Dc0GXvl

#MentalHealth #Depression #Psychedelics

[Sansero Life Sciences @Sansero_Life]

"Dr. Sunil Aggarwal... and Kathryn Tucker... are championing a novel strategy that would make #psilocybin available using state and federal “right-to-try” laws that allow terminally ill patients access to investigational drugs."

Read to learn more: https://t.co/90qk3blVYB

[Sansero Life Sciences @Sansero_Life]

This podcast explores questions about the effectiveness of #psilocybin treatment for mental illnesses. Listen here: https://t.co/nCrGE4wqYJ

#Psilocybin #PsilocybinResearch

[Sansero Life Sciences @Sansero_Life]

Recently, 17 healthcare professionals associated with TheraPsil, a non-profit, patient-rights advocacy group, have been approved by the Federal Health Minister to possess & use #psilocybin for professional training in psilocybin therapy. Learn more: https://t.co/gBFlZyDUjL

[Sansero Life Sciences @Sansero_Life]

A 67-year-old B.C woman is said to be one of the first Canadians to receive #psilocybin for non-palliative care treatment. Read more here: https://t.co/hlmuUCdold

[Sansero Life Sciences @Sansero_Life]

A recent study is showing the positive effects of #psilocybin-assisted psychotherapy to treat major depressive disorder (MDD). 71% of participants in the study experienced "more than a 50 percent reduction in #depressive symptoms." Read more here: https://t.co/00V1XW8Ihy

[Sansero Life Sciences @Sansero_Life]

Want to tap into the always evolving Cannabis industry globally? Join our Co-Founder and Director, Irie Selkirk as she shares industry insights at the 2020 Prohibition Partners Live global conference @PPLIVE_ For more details and tickets, visit: https://t.co/OiyYOZM7RZ #PPLIVE

[Sansero Life Sciences @Sansero_Life]

“At this point, there’s no question: researchers...agree that psychedelics will be legal as pharmaceuticals in the next decade.” It’s not a matter of if, but how the legalization of #psychedelics will look federally and locally. Read more here: https://t.co/RrWogMx0xg

[Sansero Life Sciences @Sansero_Life]

Join our very own co-founder, Irie Selkirk, on November 17-20 for Prohibition Partners Live @PPLIVE_ Get your tickets at: https://t.co/OiyYOZM7RZ #PPLIVE

[Sansero Life Sciences @Sansero_Life]

“Psilocybin appeared to reduce negative affect and increase positive affect.” A 2020 research study published in Scientific Reports explores the long term effects of psilocybin on an individual's emotions and overall brain function. Read more here: https://t.co/eAwcpyHDST

[Sansero Life Sciences @Sansero_Life]

Initiative 81, the Entheogenic Plant and Fungus Policy Act of 2020 will be on the ballot for D.C. residents in November. The initiative would result in the decriminalization of #psychedelic plants and fungi: https://t.co/bR9ochReQD

[Sansero Life Sciences @Sansero_Life]

"Researchers are examining the distribution of serotonin 2A receptors to help pinpoint the brain areas affected by psychedelics." Researchers continue to explore the affects of #psychedelic mushrooms on the various stages of human consciousness: https://t.co/xpwTg116jd

[Sansero Life Sciences @Sansero_Life]

As the use and benefits of mushrooms continue to increase in North America, more people are educating themselves about the best ways to include mushrooms into their diet and lifestyle choices: https://t.co/nulM0lidPb

[Sansero Life Sciences @Sansero_Life]

“Psilocybin has proven to be an effective palliative for those suffering from end-of-life anxiety due to a terminal diagnosis, and the word is spreading.” Three Green Party MPs show support for access to #psilocybin for training purposes: https://t.co/WIWk7HI1rs